Functional Groups in the Gut Microbiome: Decoding Bacterial Metabolism and Health Implications

    innerbuddies gut microbiome testing

    Gut Bacteria and the Microbiome: Unraveling the Tiny Architects of Health

    Introduction to Functional Groups in the Gut Microbiome

    Functional groups in the gut microbiome are a central concept for understanding how complex microbial communities contribute to host physiology. Rather than focusing solely on taxonomic identity, a functional perspective groups microbes by their metabolic capabilities and the biochemical transformations they perform. This approach helps decode bacterial metabolism and link microbial activity to health outcomes. The term functional group can mean different things in microbial ecology: it can describe sets of species that share similar enzymatic repertoires, guilds that occupy the same metabolic niche, or clusters of genes and pathways that produce similar end products. For search engines and researchers alike, emphasizing keywords such as gut microbiome, functional groups, and bacterial metabolism improves discoverability and clarity.

    Why functional groups matter

    Taxonomy alone cannot capture the dynamic contributions of gut bacteria to host health. Two distantly related organisms may perform practically identical biochemical functions, while closely related strains can produce divergent metabolites. Grouping microbes by function illuminates redundancy, complementarity, and competition in the gut ecosystem. For clinicians and scientists, a functional lens helps translate metagenomic data into meaningful hypotheses about disease mechanisms, dietary interventions, and therapeutic targets.

    Core concepts and definitions

    Metabolic function refers to the biochemical reactions a microbe can carry out, often encoded by its genome as enzymes, transporters, and regulatory elements. A functional group comprises organisms or genes that contribute to a shared metabolic outcome, such as short-chain fatty acid (SCFA) production or bile acid modification. Important distinctions include:

    Recognizing these distinctions improves interpretation of shotgun metagenomics, metatranscriptomics, metabolomics, and other omics data sets.

    SEO-focused overview

    For those searching online, content that connects functional groups with practical outcomes such as bacterial metabolism, short-chain fatty acids, inflammation, and metabolic disease ranks well. Use of precise subheadings, keyword-rich phrases, and explanatory paragraphs that address common queries — What are functional groups in the gut microbiome? How do they shape health? — will improve visibility. This article is crafted to serve as a comprehensive guide linking conceptual frameworks to mechanistic detail and clinical relevance.

    Structure of this resource

    This document is organized into sequential sections that build from foundational ideas to more applied topics. Subsequent sections will explore classification of functional groups, major metabolic pathways in the gut, mechanistic interactions between microbial metabolites and host biology, disease associations, and translational strategies including diagnostics and therapeutics. Each section highlights key terms and practical examples to support both scientific inquiry and health-related applications.

    By grounding the discussion in metabolic activity rather than taxonomic labels, researchers can better predict how perturbations such as antibiotics, diet shifts, or probiotics will alter community function and ultimately influence host physiology. The remainder of this multipart article dives into the major functional groups that define gut microbial metabolism and their implications for health and disease.

    Order a test! Order annual subscription with 2 or 3 tests!
    innerbuddies gut microbiome testing

    Classification and Identification of Functional Groups

    Identifying functional groups in the gut microbiome relies on multiple complementary approaches. Advances in sequencing and computational biology enable the mapping of genes to biochemical capabilities, but functional assignment requires careful interpretation. Below we review primary methods and introduce a taxonomy of common functional groups relevant to health.

    Techniques to identify functional groups

    Shotgun metagenomics sequences entire community DNA, revealing gene content and potential metabolic pathways. By annotating genes with databases such as KEGG, MetaCyc, or eggNOG, researchers infer the presence of pathway modules and enzymatic activities. However, gene presence alone does not guarantee activity.

    Metatranscriptomics measures community RNA, showing which genes are actively transcribed. When combined with metagenomics, metatranscriptomics distinguishes between latent and expressed functions. Metaproteomics and metabolomics further validate active biochemical processes by detecting proteins and metabolites, respectively.

    Integrative multi-omics approaches map functional potential to realized metabolic output, enabling robust definition of functional groups. Computational tools such as HUMAnN, PICRUSt2, and custom pathway reconstruction pipelines are widely used to translate sequence data into functionally coherent modules.

    Major functional groups in the gut

    Functional groups are often defined by their major metabolic products or substrates. Below is a non-exhaustive list organized by ecological and biochemical roles.

    1. Fiber degraders and primary fermenters

    These organisms hydrolyze complex polysaccharides such as resistant starch, arabinoxylans, and pectin into fermentable oligosaccharides and simple sugars. Representative functions include production of carbohydrate-active enzymes (CAZymes) like glycoside hydrolases and polysaccharide lyases. Prominent taxa include members of the genera Bacteroides, Ruminococcus, and Faecalibacterium, though functionally similar enzymes exist across diverse lineages. Primary fermentation yields substrates for other guilds, notably SCFA producers and cross-feeders.

    2. Short-chain fatty acid producers

    SCFAs such as acetate, propionate, and butyrate are central metabolites with systemic effects. Functional groups that generate SCFAs possess pathways like the acetyl-CoA pathway for butyrate synthesis, the succinate pathway for propionate, and varied routes to acetate. Key enzymatic markers such as butyryl-CoA:acetate CoA-transferase indicate butyrate producers. Butyrate-producing bacteria include Faecalibacterium prausnitzii, Eubacterium rectale, and Roseburia spp., and they are important for colonic epithelial health and anti-inflammatory signaling.

    3. Proteolytic fermenters and amino acid metabolizers

    When dietary carbohydrate is scarce, some microbes ferment proteins and amino acids, producing branched-chain fatty acids (BCFAs), ammonia, phenolic compounds, and other potentially toxic metabolites. These functional groups include species capable of deaminating amino acids and decarboxylating aromatic amino acids, with implications for mucosal integrity and colonocyte health.

    4. Bile acid modifiers

    Gut bacteria transform primary bile acids into secondary bile acids via deconjugation, dehydroxylation, and epimerization. Genes such as bile salt hydrolases (BSH) and 7alpha-dehydroxylase are hallmarks of this functional group. Bile acid modification alters lipid absorption, host signaling through FXR and TGR5 receptors, and microbial community structure itself.

    5. Mucin degraders and mucosal colonizers

    Mucin-degrading microbes express glycosidases targeting host mucins and can occupy the mucus niche. While mucin degradation supports nutrient cycling, excessive mucin consumption can thin the mucus barrier and increase susceptibility to inflammation and pathogen access. Akkermansia muciniphila is a well-known mucin degrader associated with metabolic health in some contexts.

    6. Hydrogenotrophs and gas modulators

    Hydrogen, formate, and other gases produced during fermentation must be removed or consumed. Functional groups such as methanogens (archaea), sulfate-reducing bacteria, and acetogens consume hydrogen and influence fermentation thermodynamics. These interactions modulate gas accumulation, redox balance, and the overall efficiency of microbial metabolism.

    7. Secondary metabolite producers and antimicrobial producers

    Certain functional groups synthesize bacteriocins, lanthipeptides, and small molecules that influence competition and cooperation. These metabolites can shape community composition and confer colonization resistance against pathogens. Functional annotation of biosynthetic gene clusters (BGCs) is an expanding area linking microbiome composition to ecological function.

    Challenges in classification

    Functional classification faces challenges including horizontal gene transfer, strain-level variation, and context-dependent gene expression. Environmental factors such as diet, host genetics, and immune state modulate which functions are active. Therefore, functional group assignments should be considered probabilistic and validated with expression and metabolite data when possible.

    Understanding these groups provides a framework for interpreting how perturbations change community metabolism and how metabolic outcomes relate to host physiology. The next section will explore specific metabolic pathways and chemical transformations that underlie these functional groups.

    Hormone-Related Bacteria in the Gut Microbiome: Unraveling Microbial Endocrinology and Its Health Implications Key Gut Species: Core Bacteria Driving the Gut Microbiome
    innerbuddies gut microbiome testing

    Gut Bacteria and the Microbiome: Unraveling the Tiny Architects of Health

    Key Metabolic Pathways and Chemical Transformations

    The metabolic landscape of the gut is defined by a network of biochemical routes that transform dietary and host-derived substrates into metabolites with local and systemic effects. This section decodes major pathways, identifying enzymatic markers, substrates, products, and cross-feeding relationships. Emphasizing these pathways clarifies how distinct functional groups contribute to host health and disease.

    Carbohydrate fermentation and SCFA production

    Complex carbohydrates escaping host digestion reach the colon where they are hydrolyzed and fermented. The central products of carbohydrate fermentation are short-chain fatty acids (SCFAs): acetate, propionate, and butyrate. Each SCFA arises from distinct pathways and has unique effects.

    Butyrate is primarily produced via the acetyl-CoA pathway and requires enzymes such as butyryl-CoA dehydrogenase and butyryl-CoA:acetate CoA-transferase or butyrate kinase. Butyrate serves as the preferred energy source for colonocytes, promotes epithelial barrier integrity, and exerts anti-inflammatory effects via histone deacetylase inhibition and activation of G-protein coupled receptors like GPR43 and GPR109A.

    Propionate can be produced through the succinate pathway, the acrylate pathway, or the propanediol pathway depending on substrate availability. Propionate modulates gluconeogenesis and lipid metabolism through hepatic signaling and may influence satiety via enteroendocrine pathways.

    Acetate is the most abundant SCFA and is produced broadly across taxa. It serves as a substrate for peripheral tissues and for other microbes, such as butyrate producers that use acetate as a co-substrate. The balance between acetate, propionate, and butyrate reflects diet, community composition, and cross-feeding dynamics.

    Cross-feeding and syntrophy

    Microbial metabolism is interconnected. Primary degraders liberate oligosaccharides and simple sugars that feed secondary fermenters. Hydrogen produced by fermenters is consumed by methanogens, sulfate-reducing bacteria, or acetogens, which stabilizes fermentation by maintaining favorable redox conditions. These syntrophic interactions influence product yields and ecological stability.

    Protein fermentation and production of nitrogenous metabolites

    Proteolytic fermentation yields ammonia, amines, phenols, indoles, and branched-chain fatty acids. Amino acid fermentation pathways such as Stickland reactions and deamination produce a range of metabolites that can be cytotoxic or modulate host signaling. For example, tryptophan metabolism generates indole derivatives that act on the aryl hydrocarbon receptor (AhR), influencing mucosal immunity and barrier function.

    Bile acid metabolism

    Bile acids synthesized by the liver are conjugated and released into the intestine, where bacterial enzymes deconjugate and modify them. Bile salt hydrolases remove taurine or glycine conjugates, while 7alpha-dehydroxylation converts primary bile acids into secondary forms such as deoxycholic acid and lithocholic acid. Modified bile acids have differential affinities for host receptors such as FXR and TGR5 and thus modulate metabolism, inflammation, and even carcinogenesis risk. Bile acid transformations also shape microbial community structure, as some secondary bile acids are antimicrobial.

    Hydrogen, methane, and sulfur cycling

    Hydrogen accumulation inhibits fermentation. Hydrogenotrophic microbes alleviate this by converting hydrogen into methane (methanogenesis), acetate (acetogenesis), or hydrogen sulfide (via sulfate reduction). Hydrogenotroph composition influences gas production profiles and has implications for conditions like bloating and irritable bowel syndrome. Of note, hydrogen sulfide is a potent signaling molecule at low concentrations but can damage the mucosa at higher levels.

    Microbial transformation of xenobiotics and drugs

    Functional groups capable of xenobiotic metabolism can activate, inactivate, or otherwise modify drugs and dietary compounds. Enzymes such as azoreductases, nitroreductases, and beta-glucuronidases mediate these reactions. For instance, microbial beta-glucuronidase activity can reactivate drug metabolites excreted into the gut, affecting drug toxicity and efficacy.

    Secondary metabolite biosynthesis and signaling molecules

    Microbial biosynthetic gene clusters yield small molecules that act on the host and on other microbes. These include bacteriocins, lantibiotics, and quorum sensing molecules. Some metabolites modulate immune responses or epithelial signaling, thereby linking microbial community structure with host physiology beyond simple nutrient exchange.

    Systems perspective on metabolic flux

    Pathway flux depends on substrate availability, community composition, and host factors. Diet profoundly shifts the balance among carbohydrate fermenters, proteolytic fermenters, and hydrogen consumers. For example, a high-fiber diet promotes SCFA-producing functional groups, while high-protein or high-fat diets may favor proteolytic fermenters and bile acid modifiers. Computational metabolic modeling, including constraint-based reconstructions and community metabolic models, helps predict flux changes in response to perturbations and can guide dietary or therapeutic interventions.

    Understanding these pathways reveals how functional groups collectively shape the chemical milieu of the gut and how their metabolites act as signaling molecules, energy substrates, and modulators of disease processes. The next section examines how these microbial functions interface with host physiology and contribute to health outcomes.

    Order a test! Order annual subscription with 2 or 3 tests!
    innerbuddies gut microbiome testing

    Host-Microbe Interactions and Health Implications

    Microbial functional groups generate metabolites that interact with host cells, influencing immunity, metabolism, and even behavior. This section connects specific metabolic activities to health outcomes, outlining mechanisms and highlighting evidence linking functional dysbiosis to disease.

    Immune modulation and inflammation

    SCFAs, particularly butyrate, have potent anti-inflammatory properties. Butyrate promotes regulatory T cell differentiation, enhances epithelial barrier integrity, and suppresses pro-inflammatory cytokine production through epigenetic and receptor-mediated mechanisms. Conversely, proteolytic fermentation products such as p-cresol and hydrogen sulfide can damage the mucosa or provoke inflammation when produced in excess. Dysregulation of mucin degraders can expose epithelium to pathogens, triggering immune activation.

    Microbially derived metabolites also influence innate immune sensing via pattern recognition receptors and metabolite-sensing receptors. For instance, AhR ligands produced from tryptophan metabolism modulate mucosal immunity and barrier function, while secondary bile acids signal through TGR5 and FXR to shape inflammatory responses.

    Metabolic disease and energy homeostasis

    Functional groups influence host energy balance through SCFA signaling and modulation of bile acid pools. Propionate has been implicated in hepatic gluconeogenesis regulation, while acetate may be used by peripheral tissues and contribute to lipogenesis. Modulation of bile acid signaling affects lipid and glucose metabolism via FXR-controlled pathways. Observational and mechanistic studies link shifts in butyrate-producing microbes with obesity, insulin resistance, and nonalcoholic fatty liver disease, though causality requires careful experimental validation.

    Gut-brain axis and neuroimmune signaling

    Gut microbial metabolites cross-talk with the nervous system through neural, endocrine, and immune routes. SCFAs stimulate enteroendocrine cells to release peptide hormones that affect appetite and mood. Tryptophan metabolites and neurotransmitter precursors produced by microbes influence serotonin and GABA systems. Emerging evidence connects functional group composition to anxiety, depression, and cognitive function through metabolite-mediated signaling and systemic inflammation modulation.

    Colon health and colorectal cancer risk

    Butyrate supports colonocyte health and can suppress tumorigenesis through epigenetic regulation and apoptosis of transformed cells. In contrast, certain secondary bile acids and proteolytic metabolites may promote DNA damage and inflammation, increasing colorectal cancer risk. Functional shifts toward proteolytic fermentation and bile acid transformation are epidemiologically associated with higher cancer risk, though interactions with diet, host genetics, and inflammation complicate the picture.

    Infectious disease susceptibility and colonization resistance

    Functional groups that produce SCFAs and antimicrobial metabolites contribute to colonization resistance by lowering luminal pH, competing for nutrients, and producing inhibitory compounds. Antibiotic disruption often reduces SCFA producers and bacteriocin-producing strains, creating ecological space for pathogens such as Clostridioides difficile. Restoring functional redundancy in SCFA production and bile acid metabolism is critical for resisting recolonization by opportunistic pathogens.

    Systemic inflammation and autoimmune disease

    Microbial metabolites influence systemic immune tone. Dysbiosis characterized by reduced SCFA producers and increased proteolytic fermenters correlates with heightened systemic inflammation and has been linked to autoimmune diseases including rheumatoid arthritis and multiple sclerosis in observational and animal studies. Experimental models suggest that microbial metabolites can modulate Th17/Treg balance and blood-brain barrier integrity, with potential implications for autoimmune conditions.

    Personalized responses and interindividual variability

    Host genetics, diet, medication use, geography, and early-life exposures shape the baseline composition and functional potential of the gut microbiome. Consequently, interventions targeting functional groups elicit variable responses. For instance, prebiotic fibers may selectively enrich SCFA-producing groups in some individuals but have limited effect in others due to baseline community structure and the presence of key degraders. Understanding the functional baseline helps predict responsiveness and design targeted interventions.

    Clinical and diagnostic applications

    Functional biomarkers such as fecal SCFA profiles, bile acid composition, and enzymatic activity assays (e.g., beta-glucuronidase) provide clinically relevant readouts of microbial function. Metagenomic functional profiling can identify deficits in key pathways—like butyrate synthesis—in patients with inflammatory bowel disease or metabolic syndrome. These functional insights guide therapeutic choices, such as selecting fiber types to support specific degraders or using bile acid modulators to restore signaling balance.

    The interplay between microbial metabolic function and host biology underscores the potential for targeted manipulation of functional groups to improve health outcomes. The final section will discuss therapeutic strategies, diagnostic innovations, and future directions for translating functional microbiome science into clinical practice.

    Hormone-Related Bacteria in the Gut Microbiome: Unraveling Microbial Endocrinology and Its Health Implications Key Gut Species: Core Bacteria Driving the Gut Microbiome
    innerbuddies gut microbiome testing

    Therapeutic Strategies and Future Directions

    Translating knowledge of gut microbial functional groups into therapies requires strategies that selectively modulate metabolic activities rather than merely shifting taxa. This final section outlines therapeutic modalities, design principles for interventions, and promising research frontiers that aim to harness microbial metabolism for health.

    Diet-based interventions: prebiotics and dietary fibers

    Diet is the most powerful modulator of microbiome function. Prebiotics and specific dietary fibers selectively stimulate beneficial functional groups such as SCFA producers. Soluble fermentable fibers like inulin and resistant starch increase butyrate-producing populations and raise fecal SCFA levels. Designing precision nutrition approaches involves matching fiber types to the enzymatic capabilities of an individual’s microbiome; this may improve consistency of response across populations.

    Probiotics and live biotherapeutics

    Probiotics aim to introduce beneficial functions, but strain selection must be function-forward. Live biotherapeutic products that deliver defined metabolic functions—such as engineered butyrate producers or bile salt hydrolase-positive strains—hold promise. Clinical success depends on engraftment potential, metabolic compatibility with resident communities, and safety. Regulatory frameworks increasingly recognize the need for functional evidence in probiotic claims.

    Postbiotics and metabolite-based therapies

    Direct administration of microbial metabolites or metabolite analogs offers a targeted approach. Examples include butyrate enemas for local colonic therapy or pharmacological modulation of bile acid receptors. Postbiotic strategies circumvent engraftment challenges but require careful dosing to mimic physiological signaling without adverse effects.

    Fecal microbiota transplantation and consortia engineering

    Fecal microbiota transplantation (FMT) transfers whole-community functional potential and has proven effective for recurrent C. difficile infection. For broader applications, rationally designed consortia that restore or replace specific functional groups may provide safer, standardized alternatives to FMT. Such consortia could include complementary taxa that provide primary degradation, cross-feeding, and colonization resistance functions.

    Small molecule and enzyme inhibitors

    Targeting microbial enzymes with small molecules can modulate metabolic outputs. For example, inhibitors of microbial beta-glucuronidase reduce reactivation of certain drug metabolites and mitigate gastrointestinal toxicity. Similarly, selective inhibitors of bacterial bile acid-transforming enzymes could alter bile pools and host signaling. These approaches require high specificity to avoid broad microbiome disruption.

    Phage therapy and precision editing

    Bacteriophages and CRISPR-based tools offer routes to selectively target taxa that contribute deleterious functions while leaving beneficial functional groups intact. Precision editing of microbial genes in situ remains technically challenging but could one day enable direct alteration of metabolic capacities without wholesale community disruption.

    Diagnostics and functional readouts

    Clinical translation requires robust diagnostics that measure function rather than composition alone. Emerging assays include targeted metabolomics, enzyme activity profiling, and functional gene qPCR panels. Integration of multi-omics with clinical metadata supports personalized intervention strategies by identifying functional deficits or overactive pathways amenable to correction.

    Research frontiers and priorities

    Ethical and regulatory considerations

    Manipulating the microbiome raises ethical questions about long-term ecological impacts and privacy concerns related to microbiome-derived diagnostics. Regulatory pathways must balance innovation with rigorous evidence of safety and efficacy, especially for live biotherapeutic and gene-editing approaches. Transparent reporting, standardized functional assays, and randomized controlled trials are essential for responsible translation.

    Concluding perspectives

    Viewing the gut microbiome through the lens of functional groups reframes questions of health and disease. By decoding bacterial metabolism and identifying the pathways that matter, researchers and clinicians can design interventions that promote beneficial functions such as SCFA production, maintain mucosal integrity, and reduce harmful metabolites. The future of microbiome medicine will rely on integrated diagnostics, precision nutrition, and targeted therapies that manipulate function rather than composition alone. Continued advances in multi-omics, computational modeling, and synthetic biology are poised to accelerate progress toward personalized strategies that harness the metabolic power of the gut microbiome to improve human health.

    Key terms: gut microbiome, functional groups, bacterial metabolism, short-chain fatty acids, bile acids, metagenomics, metabolomics, probiotics, prebiotics, postbiotics, colonization resistance.

    Hormone-Related Bacteria in the Gut Microbiome: Unraveling Microbial Endocrinology and Its Health Implications Key Gut Species: Core Bacteria Driving the Gut Microbiome

    Find more details about Functional Groups

    You can find more information on the related topics below.

    Read more: Functional Groups in the Gut Microbiome — Decoding Bacterial Metabolism and Health Implications

    View more articles

    Areas where InnerBuddies gut microbiome testing can make a significant impact

    • Digestive Health

      Gut discomfort like bloating, constipation, gas, or diarrhea often stems from an imbalance in gut bacteria. InnerBuddies analyzes the composition and diversity of your gut microbiome, identifying specific imbalances such as low fiber-fermenting bacteria or an overgrowth of gas-producing microbes.

      By pinpointing the root causes of digestive issues, InnerBuddies provides personalized, evidence-based recommendations to support digestion. Whether through targeted diet changes, prebiotics, or probiotics, users can take actionable steps to restore harmony and improve GI comfort.

    • Immune Function

      Over 80% of the immune system resides in the gut, and a diverse microbiome plays a key role in training immune cells to respond appropriately. InnerBuddies helps users assess their microbiome’s ability to support immune balance and resilience.

      Low microbial diversity or the presence of inflammatory bacteria may indicate a weakened defense system. InnerBuddies delivers tailored suggestions—like anti-inflammatory foods or immune-supportive nutrients—to help build a stronger, more balanced immune response.

    • Mental Health & Mood (Gut-Brain Axis)

      Emerging research shows that your microbiome influences neurotransmitters like serotonin, dopamine, and GABA, directly affecting mood and stress levels. InnerBuddies evaluates gut-brain axis markers to explore how your microbes may be impacting your mental well-being.

      With insight into bacterial strains associated with anxiety, depression, or stress resilience, InnerBuddies can guide personalized strategies to help improve emotional balance—ranging from fiber-rich diets to psychobiotic supplements.

    • Weight Management & Metabolism

      Certain gut bacteria can extract more energy from food and influence fat storage, insulin sensitivity, and appetite hormones. InnerBuddies assesses metabolic markers in your microbiome profile to help reveal how your gut may be impacting your weight.

      With tailored advice on foods that support healthy metabolism—such as resistant starches or polyphenol-rich plants—InnerBuddies empowers users to make microbially informed decisions that complement their health goals and weight management strategies.

    • Skin Health

      Skin conditions like acne, eczema, and rosacea are increasingly linked to gut imbalances and systemic inflammation. InnerBuddies analyzes your microbiome to detect patterns that may contribute to inflammatory skin responses.

      By supporting gut barrier integrity and reducing pro-inflammatory microbes, the recommendations from InnerBuddies can help improve skin from the inside out—encouraging a clearer complexion and fewer flare-ups through gut-skin axis awareness.

    • Personalized Nutrition

      Not all foods are beneficial for every gut. InnerBuddies delivers customized nutrition insights based on your unique microbial profile—identifying foods that nourish beneficial bacteria and flagging those that may trigger dysbiosis.

      This personalized approach helps users move beyond one-size-fits-all diets and embrace gut-friendly nutrition strategies. Whether you’re optimizing for energy, digestion, or longevity, InnerBuddies transforms your microbiome data into actionable meal plans.

    Hear from our satisfied customers!

    • "I would like to let you know how excited I am. We had been on the diet for about two months (my husband eats with us). We felt better with it, but how much better was really only noticed during the Christmas vacations when we had received a large Christmas package and didn't stick to the diet for a while. Well that did give motivation again, because what a difference in gastrointestinal symptoms but also energy in both of us!"

      - Manon, age 29 -

    • "Super help!!! I was already well on my way, but now I know for sure what I should and should not eat, drink. I have been struggling with stomach and intestines for so long, hope I can get rid of it now."

      - Petra, age 68 -

    • "I have read your comprehensive report and advice. Many thanks for that and very informative. Presented in this way, I can certainly move forward with it. Therefore no new questions for now. I will gladly take your suggestions to heart. And good luck with your important work."

      - Dirk, age 73 -